Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Pharmaceutical Manufacturing of Imatinib Mesylate

Active

Federal

Response Deadline10/16/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the pharmaceutical manufacturing of Imatinib Mesylate tablets to support prime contractors on Department of Veterans Affairs supply projects. The selected provider must produce the drug in 100MG and 400MG strengths within FDA-approved facilities, ensuring all products meet strict federal pharmaceutical standards. A critical requirement for the offeror is the provision of a unique National Drug Code number belonging solely to their organization. The scope of work includes the delivery of finished tablets across both base and option years. Managed under NAICS code 325412 and issued by Nac Pharmaceuticals for the Department of Veterans Affairs, the opportunity was posted on October 5, 2026, with a response deadline of October 16, 2026.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0036.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Imatinib Tablets

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 5

subcontract

Response DeadlineOct 16

Submission deadline

Response Deadline

10/16/2026, 07:30:00 PM UTCin 10 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies Imatinib Mesylate tablets for prime contractors on Department of Veterans Affairs pharmaceutical supply projects. Manufactures drug products in 100MG and 400MG strengths to meet federal pharmaceutical standards using FDA-approved facilities. Requires a unique National Drug Code (NDC) number belonging solely to the offeror. Delivers finished Imatinib Mesylate tablets for base and option years.

Similar Contracts

Same NAICS industry code

Zinc Oxide Ointment SupplierThis subcontract involves the supply of Zinc Oxide Ointment to prime contractors supporting the Department of Defense through the Medical Supply Chain Pharm FSA. The supplier is responsible for providing 15 units of a 20 percent concentration topical skin protectant that adheres to USP standards, packaged in 1oz collapsible tubes. To ensure product integrity, the ointment must be maintained in temperature-controlled storage that does not exceed 30 degrees Celsius. The contract is categorized under NAICS code 325412 and is associated with performance in Oklahoma City. Interested parties should note the posting date of October 5, 2026, with a response deadline set for October 13, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

Supply of Levofloxacin Tablets (250 MG)This subcontract involves the supply of 250 MG Levofloxacin Tablets to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain Pharm FSA. The requirement is for 10 bottles, each containing 50 pharmaceutical-grade tablets that must strictly adhere to FDA regulations. The selected provider must utilize FDA-regulated distribution facilities and ensure that all products are stored and transported at medical controlled room temperature. Additionally, the supplier must certify a non-extendable shelf life of 24 months for the delivered medication.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

Supply of Hydrogen Peroxide Topical SolutionThis subcontract involves the supply of 3% Hydrogen Peroxide Topical Solution (NSN 6505-01-659-1491) to prime contractors supporting DLA Troop Support medical supply contracts. The product must be provided in 4-ounce bottles packaged in cases of 24, ensuring a total shelf life of 24 months from the date of delivery. All supplies must adhere to OTC pharmaceutical standards for external use and comply with FAR 52.223-3 regarding hazardous material identification. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract is categorized under NAICS code 325412. The designated place of performance is Fort Bliss, Texas. Interested parties should note the response deadline of October 13, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

ZINC OXIDE OINTMENT

Solicitation # SPE2DP-27-T-0041

Solicitation SPE2DP-27-T-0041, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Zinc Oxide Ointment USP. The required product is a topical skin protectant containing 20% zinc oxide, delivered in 1oz (28.4gm) collapsible tubes. The solicitation consists of two line items: CLIN 0001 for 10 units and CLIN 0002 for 5 units. The items must be stored at controlled room temperature not exceeding 30 degrees Celsius (86 degrees Fahrenheit) and have a non-extendable shelf life of 36 months. Delivery is required within 5 days after order, with an original required delivery date of October 2, 2026. Shipping is FOB Destination, with inspection and acceptance also occurring at the destination. The contractor must use the fastest traceable means for shipping and is prohibited from using Parcel Post. Packaging must comply with RP001 DLA Packaging Requirements and MIL-STD-129, with specific medical marking required per Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it shall be commercially packaged per ASTM D3951. The contract incorporates various FAR and DFARS clauses, including requirements for combating trafficking in persons, safeguarding covered defense information, and adherence to the Buy American and Balance of Payments Program for quotes above the micro-purchase threshold. Payment and invoicing must be processed electronically through the Wide Area WorkFlow system. This is an FDA-regulated drug or device, and the contracting official must confirm the product specialist's referral in EBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

PROCAINAMIDE HYDROC

Solicitation # SPE2DP-26-T-5314

Solicitation SPE2DP-26-T-5314 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm for the procurement of Procainamide Hydrochloride Injection, USP. The requirement is for two packages, with each package containing 25 vials of 100 mg/mL, 10 mL (NSN 6505-01-240-8703). The specified product is manufactured by Pfizer Inc under part number NDC00409-1902-01. The item must have a non-extendable shelf life of 24 months, with at least 21 months remaining upon delivery to the government. Delivery is required within five days after receipt of order, with FOB, inspection, and acceptance all occurring at the destination. The contractor must adhere to strict medical packaging and marking standards, specifically Medical Marking Standard No. 1 and 1C, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage. The solicitation incorporates various FAR and DFARS clauses, including requirements for the Buy American and Balance of Payments Program, safeguarding covered defense information, and hazardous material labeling per 29 CFR 1910.1200. Quotes must be submitted via the DLA Internet Bid Board System by October 5, 2026, and must include the bidder's contact information, manufacturer details, and item description. Payment requests and receiving reports are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-5322

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-27-T-0069

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

ZINC OXIDE OINTMENT

Solicitation # SPE2DP-27-T-0065

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

PETROLATUM, WHITE

Solicitation # SPE2DP-26-T-5256

Solicitation SPE2DP-26-T-5256, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, seeks quotes for the procurement of 25 packages of White Petrolatum USP. Each package must contain 144 individual units of 100 percent active ingredient White Petrolatum USP, with each unit weighing 5 grams. The material is subject to a total shelf life of 36 months, with a minimum of 31 months remaining upon receipt by the first government activity. Storage is required at room temperature between 15 and 30 degrees Celsius. Delivery is specified as FOB Destination to Fort Bragg, North Carolina, with a required lead time of 20 days. Packaging must be commercial and compliant with MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129. Required labels must include the National Stock Number, manufacturer, contract number, lot number, and the date of manufacture, expiration, or retest. Inspection and acceptance will occur at the destination. The procurement is governed by the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105 and incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, Berry Amendment, and safeguarding covered defense information. Contractors are required to use the Wide Area WorkFlow system for electronic invoicing and payment requests.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

VECURONIUM BROMIDE FOR

Solicitation # SPE2DP-26-T-5284

Solicitation SPE2DP-26-T-5284 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Vecuronium Bromide for Injection. The required product is a freeze dried powder containing 10mg of active ingredient, supplied in packages of 10 vials. The total shelf life of the product is 24 months, with a mandatory minimum of 21 months remaining upon receipt by the first government activity. The solicitation includes two line items, each for a quantity of 3 packages, with required delivery dates set for September 29 and September 30, 2026. Delivery is specified as FOB Destination to AFMEDCOM CSDC West at Travis AFB, California, with a delivery window of 20 days after the order. Compliance with strict packaging and marking standards is required, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking. Packaging must follow RP001 DLA requirements, with non-hazardous materials adhering to ASTM D3951 and hazardous materials following TQ requirement IP025 per FED-STD-313. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons. All quotes must be submitted electronically via the DLA Internet Bid Board System, and successful vendors must utilize the Wide Area WorkFlow system for invoicing and payment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

SODIUM CHLORIDE INJ

Solicitation # SPE2DP-26-T-5315

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-27-T-0068

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

Pharmaceutical Labeling and Printing ServicesThis subcontract for Pharmaceutical Labeling and Printing Services involves the professional production of pharmaceutical labels for prime contractors supporting Department of Veterans Affairs supply projects. Specifically, the contractor is responsible for printing labels for Imatinib Mesylate bottles, ensuring each label measures 5.25 by 2 inches with a dedicated 0.5-inch space for barcodes and expiration data. The technical requirements specify the use of adhesive materials compatible with VA over-labeling and the inclusion of the contractor's unique NDC number. Managed under NAICS code 323111 for Nac Pharmaceuticals, the project is associated with the Department of Veterans Affairs and has a response deadline of October 16, 2026.

Commercial Printing (except Screen and Books)

POSTED

about 23 hours ago

DEADLINE

Specialized Pharmaceutical Packaging SupplyThis subcontract, titled Specialized Pharmaceutical Packaging Supply, involves the provision of medical-grade bottles and safety caps to prime contractors supporting Department of Veterans Affairs pharmaceutical projects. The scope of work requires the manufacture of cylindrical bottles with a minimum volume of 120cc and a circumference of at least 5.75 inches. Additionally, the supplier must provide convertible or deshellable safety caps that are designed not to exceed the diameter of the bottles. Managed by Nac Pharmaceuticals under NAICS code 326199, the contract focuses on the bulk delivery of compliant packaging materials. The opportunity was posted on October 5, 2026, with a response deadline set for October 16, 2026.

All Other Plastics Product Manufacturing

POSTED

about 23 hours ago

DEADLINE

6505--Imatinib Tablets

Solicitation # 36E79726R0036

The Department of Veterans Affairs, through the OPAL National Acquisition Center, intends to issue Request for Proposal 36E79726R0036 for an unrestricted procurement of Imatinib Mesylate Tablets. This contract will establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution managed via the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four pre-priced one-year option periods. Estimated annual requirements include 6,397 bottles of 100MG tablets (90 count) and 23,212 bottles of 400MG tablets (30 count). The procurement is governed by FAR Part 12 for commercial items under NAICS code 325412. Strict packaging and labeling standards are required: bottles must be cylindrical with a minimum 120cc volume, a minimum 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Labels must measure 5.25 by 2 inches, leaving a 0.5 inch space for barcodes and expiration data, and must feature a unique NDC number belonging solely to the offeror. The contractor's label must be the only one on the product and must allow VA labels to adhere securely on top. The solicitation is expected to be issued electronically via SAM.gov on or about October 16, 2026, with a tentative closing date of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

about 23 hours ago

DEADLINE

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves providing specialized logistics support for prime contractors serving the Department of Veterans Affairs and Department of Defense Pharmaceutical Prime Vendor Programs. The scope of work includes managing cold chain transport and storage, coordinating shipments to CMOPs and TMOPs, and maintaining inventory levels to ensure an uninterrupted supply of medical products delivered to program hubs. The contractor must operate in strict compliance with the Drug Supply Chain Security Act and Good Distribution Practices. This opportunity is categorized under NAICS code 424210 and is associated with Nac Pharmaceuticals. Interested parties should note the response deadline of October 16, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Labeling and Packaging ServicesThis subcontract for Pharmaceutical Labeling and Packaging Services supports prime contractors on Department of Veterans Affairs pharmaceutical projects. The scope of work involves the production and delivery of compliant packaging components, specifically focusing on labels featuring unique NDC numbers and bottle caps that adhere to the American Academy of Ophthalmology color-coding system. To ensure operational integrity, the provider utilizes medical-grade adhesives to securely affix VA labels over existing contractor labels. Managed under NAICS code 323111 for Nac Pharmaceuticals, the opportunity was posted on October 2, 2026, with a response deadline of October 16, 2026. The contract ensures that all specialized labeling and packaging materials meet the strict regulatory and safety requirements necessary for pharmaceutical distribution within the VA system.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Latanoprost Ophthalmic Solution ManufacturingThis subcontract involves the manufacturing of Latanoprost Ophthalmic Solution to support prime contractors on pharmaceutical procurement projects for the Department of Veterans Affairs. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and sterile filling into ocular medication containers. All operations must be conducted within cleanrooms using pharmaceutical-grade API and in strict adherence to current Good Manufacturing Practices. To ensure safety and standardization, the manufacturer must follow the American Academy of Ophthalmology’s uniform color-coding system for all labels and caps. The final deliverable consists of finished, labeled, and packaged solutions assigned a unique NDC number. This project is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026, under NAICS code 325412. Strict labeling and packaging requirements apply to this procurement. Offerors must provide the exact drug name as it appears on the label and a unique NDC number. The contractor's label must be the sole label on the product, and affixing labels over existing ones is prohibited; however, the label must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. All communications and submissions are to be handled electronically via SAM.gov, with James Sullivan serving as the primary point of contact.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Prednisolone 1% Ophthalmic Solution

Solicitation # 36E79726R0037

The Department of Veterans Affairs, through the OPAL Enterprise Procurement Office, is soliciting offers for the procurement of Prednisolone Acetate 1% Ophthalmic Suspension. This unrestricted procurement is designated as a HUBZONE Small Business set-aside and aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Supplies will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs, with requirements for three package sizes: 5ml, 10ml, and 15ml bottles. Award will be made to a single responsible offeror for all line items based on the Lowest Price Technically Acceptable (LPTA) approach. To be considered technically acceptable, offerors must provide FDA-approved pharmaceuticals with unique 11-digit NDC numbers and demonstrate that manufacturing facilities are FDA cGMP acceptable. Strict packaging and labeling standards are required, including GS1-128 or HIBC linear bar codes and 2D data matrix bar codes per the Drug Supply Chain Security Act. Proposals must be submitted by October 14, 2026, and must include a signed SF-1449, a 0.5% cost recovery fee in the pricing, and a letter of commitment from the manufacturer if the offeror is not the producer.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Labeling and Packaging SupplierThis subcontract with Nac Pharmaceuticals for the Department of Veterans Affairs involves the supply of medical-grade pharmaceutical packaging for approximately 462,000 units. The scope of work includes providing 5 ML and 10 ML bottles designed for compatibility with 5.25 by 2 inch labels, specifically ensuring a 0.5 inch space for barcodes and lot numbers. The supplier is responsible for providing adhesive label stock that supports secure VA over-labeling without the need for additional over-labeling. This procurement falls under NAICS code 326199 and was posted on September 25, 2026, with a response deadline of October 15, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Prednisolone Acetate 1% Ophthalmic Suspension ManufacturerNac Pharmaceuticals is seeking a subcontractor to manufacture and supply Prednisolone Acetate 1% Ophthalmic Suspension for Department of Veterans Affairs pharmaceutical supply contracts. The selected provider will be responsible for the formulation, production, filling, and sealing of both 5 ML and 10 ML bottles within sterile manufacturing facilities. To qualify, the manufacturer must maintain FDA registration, ensure full cGMP compliance, and possess a unique NDC number. The annual delivery requirements consist of 392,107 bottles of the 5 ML size and 70,070 bottles of the 10 ML size. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 15, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves the supply and distribution of Glipizide Tablets to prime contractors supporting various government entities, including the VA, DoD, BOP, IHS, and FHCC. The scope of work encompasses comprehensive warehousing, inventory management, and FOB Destination shipping specifically tailored for Consolidated Mail Order Pharmacies and State Veterans Homes. To ensure product integrity, the operations utilize climate-controlled warehousing and specialized pharmaceutical transport vehicles for delivery to designated government destinations. Managed by Nac Pharmaceuticals under the Department of Veterans Affairs, the contract falls under NAICS code 424210, with a response deadline set for October 8, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the packaging and labeling of Glipizide Tablets to support prime contractors delivering pharmaceutical supplies to the VA, DoD, BOP, IHS, and FHCC. The scope of work includes bottling, blister packing, and the application of labels that meet specific VA and DoD requirements using specialized pharmaceutical machinery. All operations must strictly adhere to FDA cGMP standards and the requirements outlined in Section 5 of the contract scope to ensure the tablets are ready for final shipment. This opportunity is issued by Nac Pharmaceuticals under the Department of Veterans Affairs, with a response deadline of October 8, 2026.

All Other Miscellaneous Manufacturing

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS